24 Results for "

Myelin oligodendrocyte glycoprotein

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "Myelin oligodendrocyte glycoprotein" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-P1240
CAS No.: 149635-73-4
Synonyms: Myelin oligodendrocyte glycoprotein Peptide (35-55), mouse, rat
MOG (35-55) mouse, rat (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) is a minor component of CNS myelin. MOG (35-55) mouse, rat has encephalitogenic activity and induces T cell proliferative. MOG (35-55) mouse, rat induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) mouse, rat produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) mouse, rat (MOG (35-55)) can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-P1240B
Synonyms: Myelin oligodendrocyte glycoprotein Peptide (35-55), mouse, rat acetate
MOG (35-55) (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) acetate is a minor component of CNS myelin. MOG (35-55) (acetate) has encephalitogenic activity and induces T cell proliferative. MOG (35-55) (acetate) induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) (acetate) produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) (Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat) acetate can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-P1240A
Synonyms: Myelin oligodendrocyte glycoprotein Peptide (35-55), mouse, rat TFA
MOG (35-55) (MOG (35-55)) TFA is a minor component of CNS myelin. MOG (35-55) (TFA) has encephalitogenic activity and induces T cell proliferative. MOG (35-55) (TFA) induces Th1 cytokine response as well as relatively high levels of IgG antibodies. MOG (35-55) (TFA) produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. MOG (35-55) (MOG (35-55)) TFA can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P3719
CAS No.: 2022956-48-3
Target:  

CCR

Research Areas:  

Inflammation/Immunology

MOG (35-55) amide, mouse, rat the terminal amidation form of the 35-55 fragment of the myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide (MOG (35-55) (HY-P1240)). MOG(35-55) amide, mouse, rat can be used for experimental autoimmune encephalomyelitis (EAE) modeling .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70845A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MOG; MOG Alpha-5; Myelin oligodendrocyte glycoprotein; MOG AluA; Myelin-oligodendrocyte glycoprotein; MOG AluB; BTNL11; MOGIG2; BTN6; NRCLP7; MOG Ig-AluB
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P2459
CAS No.: 163158-19-8
Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

MOG (35-55), human is a synthetic encephalitogenic peptide fragment (residues 35-55) of human myelin oligodendrocyte glycoprotein, and also serves as a myelin oligodendrocyte glycoprotein peptide epitope. MOG (35-55), human induces mild central nervous system inflammation in mice, but does not trigger demyelinating lesions, only causing mild clinical neurological symptoms. MOG (35-55) induces experimental autoimmune encephalomyelitis mouse models that recapitulate the features of optic neuritis, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated diseases, and neuromyelitis optica spectrum disorders .
loading...
    loading...
Cat. No.: HY-136427
CAS No.: 79220-94-3
Purity:  98.08%
KRM-III is an orally active TCR inhibitor and NFAT inhibitor with an IC50 of 5 μM against NFAT. KRM-III has no effect on the activation of nuclear factor-κB. KRM-III inhibits T cell proliferation induced by T cell antigen receptor stimulation. KRM-III abrogates anti-CD3 antibody-induced cell activation in vivo. KRM-III reduces paw pad swelling in delayed-type hypersensitivity induced by Bovine serum albumin (HY-D0842). KRM-III alleviates the severity of experimental autoimmune encephalomyelitis (EAE) in mice. KRM-III can be used in studies related to experimental autoimmune encephalomyelitis .
loading...
    loading...
Cat. No.: HY-P5966
CAS No.: 507233-87-6
Synonyms: MOG (40-54)
Target:  

MHC

Research Areas:  

Inflammation/Immunology

Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse (MOG (40-54)) is a CD8-related self-antigenic epitope of the myelin oligodendrocyte glycoprotein (MOG) protein and is presented in association with H-2Db .
loading...
    loading...
Cat. No.: HY-P990138

Target:  

CD20

Anti-Monkey/Human CD20 Antibody (2H7) is a mouse-derived IgG2b κ type antibody inhibitor, targeting to monkey/human CD20. Anti-Monkey/Human CD20 Antibody (2H7) specifically depletes B cells. Anti-Monkey/Human CD20 Antibody (2H7) can be used for the researches of inflammation and metabolic disease, such as diabetes and experimental autoimmune encephalomyelitis .
loading...
    loading...
Cat. No.: HY-P5448
CAS No.: 159507-82-1
MOG (92-106), mouse, rat is a 15-peptide encephalitogenic epitope composed of amino acid residues 92-106 of myelin oligodendrocyte glycoprotein (MOG). MOG (92-106), mouse, rat serves as an I-A s-restricted CD4 + T cell antigen. MOG (92-106), mouse, rat also induces extensive B cell responses against secondary myelin antigens such as MBP and PLP. MOG (92-106), mouse, rat is applicable to studies on multiple sclerosis, EAE, autoimmune demyelination, and antigen-specific T/B cell responses .
loading...
    loading...
Cat. No.: HY-P2461
CAS No.: 218291-36-2
Target:  

MHC

Research Areas:  

Neurological Disease

MOG (89-113), human is a peptide fragment of human myelin oligodendrocyte glycoprotein.
loading...
    loading...
Cat. No.: HY-P3718
CAS No.: 356038-17-0
Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

MOG peptide (79-96) rat is a myelin oligodendrocyte glycoprotein (MOG) with encephalitogenic effects .
loading...
    loading...
Cat. No.: HY-112219
CAS No.: 1448422-61-4
Purity:  99.21%
Target:  

Histamine Receptor

H3R antagonist 1 is a histamine receptor 3 (H3R) inverse agonist. H3R antagonist 1 increases the expression levels of myelin-associated glycoprotein (MAG) and myeline basic protein (MBP) in differentiating oligodendrocytes. H3R antagonist 1 can be used for the study of multiple sclerosis .
loading...
    loading...
Cat. No.: HY-112219A
CAS No.: 2319790-07-1
Purity:  99.10%
Target:  

Histamine Receptor

H3R antagonist 1 hydrochloride is a histamine receptor 3 (H3R) inverse agonist. H3R antagonist 1 hydrochloride increases the expression levels of myelin-associated glycoprotein (MAG) and myeline basic protein (MBP) in differentiating oligodendrocytes. H3R antagonist 1 hydrochloride can be used for the study of multiple sclerosis .
loading...
    loading...
Cat. No.: HY-P73805
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MOG; MOG Alpha-5; Myelin oligodendrocyte glycoprotein; MOG AluA; Myelin-oligodendrocyte glycoprotein; MOG AluB; BTNL11; MOGIG2; BTN6; NRCLP7; MOG Ig-AluB
Species:  
Mouse
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-158688
CAS No.: 3048633-11-7
Target:  

PI3K

Research Areas:  

Inflammation/Immunology

PI3Kδ-IN-21 (Compound 31) is a selective inhibitor for phosphoinositide 3-kinases δ (PI3Kδ), with an IC50 of 13.6 nM. PI3Kδ-IN-21 inhibits proliferation and differentation of T cells through PI3K/AKT/mTOR signaling pathway. PI3Kδ-IN-21 exhibits good pharmacokinetic characters in rat model, and attenuates the experimental autoimmune encephalomyelitis in myelin oligodendrocyte glycoprotein (MOG)-induced EAE model .
loading...
    loading...
Cat. No.: HY-P702767
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MOG; MOG Alpha-5; Myelin oligodendrocyte glycoprotein; MOG AluA; Myelin-oligodendrocyte glycoprotein; MOG AluB; BTNL11; MOGIG2; BTN6; NRCLP7; MOG Ig-AluB
Species:  
Mouse
Source:  
P. pastoris
loading...
    loading...
Cat. No.: HY-P702768
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MOG; MOG Alpha-5; Myelin oligodendrocyte glycoprotein; MOG AluA; Myelin-oligodendrocyte glycoprotein; MOG AluB; BTNL11; MOGIG2; BTN6; NRCLP7; MOG Ig-AluB
Species:  
Mouse
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P705264
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MOG; MOG Alpha-5; Myelin oligodendrocyte glycoprotein; MOG AluA; Myelin-oligodendrocyte glycoprotein; MOG AluB; BTNL11; MOGIG2; BTN6; NRCLP7; MOG Ig-AluB
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705235
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MOG; MOG Alpha-5; Myelin oligodendrocyte glycoprotein; MOG AluA; Myelin-oligodendrocyte glycoprotein; MOG AluB; BTNL11; MOGIG2; BTN6; NRCLP7; MOG Ig-AluB
Species:  
Human
Source:  
HEK293
loading...
    loading...